Oak Street Health, Inc. (NYSE:OSH – Get Rating) insider Griffin Myers sold 50,000 shares of the firm's stock in a transaction dated Thursday, September 22nd. The shares were sold at an average price of $26.32, for a total transaction of $1,316,000.00. Following the transaction, the insider now owns 4,854,159 shares of the company's stock, valued at $127,761,464.88. The transaction was disclosed in a document filed with the SEC, which is available at this link.

Griffin Myers also recently made the following trade(s):

• On Thursday, September 8th, Griffin Myers sold 50,000 shares of Oak Street Health stock. The shares were sold at an average price of $27.39, for a total transaction of $1,369,500.00.
• On Thursday, August 25th, Griffin Myers sold 50,000 shares of Oak Street Health stock. The stock was sold at an average price of $28.95, for a total transaction of $1,447,500.00.
• On Thursday, August 11th, Griffin Myers sold 50,000 shares of Oak Street Health stock. The stock was sold at an average price of $29.08, for a total transaction of $1,454,000.00.
• On Thursday, July 28th, Griffin Myers sold 200,000 shares of Oak Street Health stock. The stock was sold at an average price of $28.63, for a total transaction of $5,726,000.00.

Oak Street Health Trading Down 5.6 %

Shares of OSH stock opened at $24.75 on Friday. The stock has a market cap of $5.97 billion, a price-to-earnings ratio of -11.25 and a beta of 3.01. The company has a quick ratio of 1.57, a current ratio of 1.57 and a debt-to-equity ratio of 16.10. Oak Street Health, Inc. has a fifty-two week low of $13.29 and a fifty-two week high of $48.87. The firm's 50 day moving average price is $27.37 and its two-hundred day moving average price is $22.97.

Analysts Set New Price Targets

OSH has been the subject of a number of recent research reports. Stifel Nicolaus lifted their price target on shares of Oak Street Health from $25.00 to $35.00 in a report on Wednesday, July 27th. Barclays lifted their price target on shares of Oak Street Health from $31.00 to $34.00 and gave the stock an "overweight" rating in a report on Monday, August 8th. Argus started coverage on shares of Oak Street Health in a research report on Tuesday, July 26th. They issued a "hold" rating on the stock. The Goldman Sachs Group cut shares of Oak Street Health from a "buy" rating to a "neutral" rating and decreased their target price for the stock from $32.00 to $29.00 in a research report on Monday, September 12th. Finally, Evercore ISI raised their target price on shares of Oak Street Health to $37.00 in a research report on Tuesday, August 9th. One analyst has rated the stock with a sell rating, six have issued a hold rating and eight have issued a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of "Hold" and a consensus price target of $32.75.

Institutional Trading of Oak Street Health

Hedge funds have recently made changes to their positions in the company. Benjamin Edwards Inc. raised its stake in shares of Oak Street Health by 9,016.7% during the first quarter. Benjamin Edwards Inc. now owns 1,094 shares of the company's stock valued at $29,000 after purchasing an additional 1,082 shares during the period. Fifth Third Bancorp purchased a new stake in shares of Oak Street Health during the first quarter valued at approximately $46,000. Gleason Group Inc. purchased a new stake in shares of Oak Street Health during the first quarter valued at approximately $54,000. Captrust Financial Advisors raised its stake in shares of Oak Street Health by 114.5% during the first quarter. Captrust Financial Advisors now owns 2,688 shares of the company's stock valued at $72,000 after purchasing an additional 1,435 shares during the period. Finally, Hardy Reed LLC purchased a new stake in shares of Oak Street Health during the first quarter valued at approximately $79,000. Hedge funds and other institutional investors own 91.33% of the company's stock.

Oak Street Health Company Profile

(Get Rating)

Oak Street Health, Inc, together with its subsidiaries, offers healthcare services to the patients in the United States. The company operates primary care centers for Medicare beneficiaries. As of December 31, 2021, it operated 129 centers in 19 states, including Illinois, Michigan, Pennsylvania, Ohio, and Texas.

Featured Stories

• Get a free copy of the StockNews.com research report on Oak Street Health (OSH)
• Will Wall Street's Enthusiasm About Datadog Lead To Big Gains?
• MarketBeat: Week in Review 9/19 – 9/23
• Why Does Tesla Stock Remain Resilient?
• 2 Semiconductor Stocks To Watch For Reversals
• Are Layoffs At A Small-Cap Tech A Bellwether For Housing Stocks?

Receive News & Ratings for Oak Street Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oak Street Health and related companies with MarketBeat.com's FREE daily email newsletter.